Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.
about
Acute myeloid leukemia in the older adultsVolasertib for AML: clinical use and patient considerationExploring Big Data in Hematological Malignancies: Challenges and Opportunities.Realising the Value of Linked Data to Health Economic Analyses of Cancer Care: A Case Study of Cancer 2015.Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patientsNationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012.Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia modelsClinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter studyOridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells.Chemotherapy options for previously untreated acute myeloid leukemia.Management of Newly Diagnosed Acute Myeloid Leukemia in the Elderly: Current Strategies and Future Directions.Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.The artful management of older patients with acute myeloid leukemia.Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse.Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.Changes in the survival of older patients with hematologic malignancies in the early 21st century.A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.Induction treatment of acute myeloid leukemia in an elderly patient with intramarrow injection/administration of cytarabine. Second case report.Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia.Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome.The management and treatment of acute leukemias in the elderly population.Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.Do adults aged 70 years or older with acute myeloid leukemia benefit from allogeneic hematopoietic cell transplantation?The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia.Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML.Frailty in Hematologic Malignancy.
P2860
Q26740584-4CEBD338-AF93-42CC-BDA2-E611C6D970BCQ26801131-76CA7C8C-5E71-425C-B4C6-1D9EB3EA7110Q31095966-2E640368-3F3E-42C8-8606-12E09693356FQ35835158-01D84835-2605-44E3-A75D-1034F451DDBFQ36337955-28646D2C-262D-4486-8A08-BD9124657944Q36441428-AE31D91D-9CC4-4337-BB02-19E03CE19D6DQ37045295-D68C4A07-59D2-4000-8E47-AFDA0F40E34BQ37545335-A70F62BD-A1F5-4445-903E-52F7BFBEB73DQ37728862-4890723F-34E4-4656-980A-8DE46FA124B0Q38585930-4BAEC710-71CB-4E56-82E0-2267FA1B06FDQ38601723-030E3DB2-C7D6-4315-B7B1-EACF46CA6167Q38636162-50BCF0DD-BF25-42AC-B185-D7C6CB977842Q38734206-00D79BBE-08AC-4C00-9599-796020B9BD2FQ38783028-056706B5-3809-4351-A92B-E159E25E5DDFQ38832223-B5E98610-96BE-442F-9622-B8A444FBAC1BQ39779257-F9DA779B-5DE6-4862-BD77-5FF6C849AAFEQ40504613-A938262B-078E-4257-A118-28E236021029Q40548451-E186DDB1-A98F-4E88-BA3D-44E66AAE4140Q41599787-3EEEEFE4-45B4-45E2-8125-8FE60F485565Q41984963-53BB15FB-48BF-46EB-9CCB-302FECAECA80Q47665959-E74A5B63-FD9E-4717-B7AE-AB5D1F3B859DQ48133412-E35C699F-90E5-40AA-BEB8-637DBFB6E856Q49987424-E6BF110D-FC07-408C-89D1-48D42E5467BFQ50075321-581DF809-4886-4CDF-B2D3-DF38AEDBD2DFQ52867206-A610EF21-C3FD-4CDC-A806-973F7B4AD75AQ54300663-8B7296BD-2B0E-4DE3-B297-8B2DCEE28DFBQ55310120-330871A5-CFE0-4D50-AE2B-CAFB0F388DBEQ55360943-937973FD-7B6A-4C08-93D2-934E83BF54F1
P2860
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Big data analysis of treatment ...... patients in the United States.
@ast
Big data analysis of treatment ...... patients in the United States.
@en
type
label
Big data analysis of treatment ...... patients in the United States.
@ast
Big data analysis of treatment ...... patients in the United States.
@en
prefLabel
Big data analysis of treatment ...... patients in the United States.
@ast
Big data analysis of treatment ...... patients in the United States.
@en
P2093
P2860
P1433
P1476
Big data analysis of treatment ...... patients in the United States.
@en
P2093
Bruno C Medeiros
Carolina Reyes
Deborah Hurst
Faiyaz Momin
Khang Q Hoang
Sacha Satram-Hoang
P2860
P304
P356
10.1007/S00277-015-2351-X
P577
2015-03-20T00:00:00Z